| Old Articles: <Older 4651-4660 Newer> |
 |
The Motley Fool March 13, 2008 Brian Lawler |
Dendreon Rolls the Dice The pharmaceutical amends a phase 3 study on its lead prostate cancer drug.  |
The Motley Fool March 12, 2008 Brian Orelli |
Will This Drug Help Schering-Plough Recover? FDA approval of Schering-Plough's muscle block medication Bridion looks certain, but will doctors see a need for it?  |
The Motley Fool March 12, 2008 Brian Lawler |
A New Wave for Third Wave Molecular-diagnostics developer Third Wave Technologies might be able to help women who test positive for a common STD.  |
The Motley Fool March 10, 2008 Brian Orelli |
Breakup Weighs Down APP It's going to take awhile for APP Pharmaceuticals to reward investors.  |
The Motley Fool March 10, 2008 Brian Orelli |
A Drug to Wake Up Schering Bridion gets an FDA panel review.  |
Job Journal March 9, 2008 |
Career Snapshot: Emergency Medical Technician (Emt) Job Prospects are good for EMTs, who bring critical care whenever and wherever it's needed.  |
Managed Care February 2008 |
Women Increasingly Fill Medical Director Role Women hold a 30 percent greater share of physician executive jobs than they did 10 years ago.  |
Managed Care February 2008 Martin Sipkoff |
Why Is It So Tough to Deliver On E-Prescribing's Promise? The push to mandate this electronic tool is increasing in intensity, but dealing with costs and coming up with standards remain obstacles  |
Managed Care February 2008 Thier et al. |
In Chronic Disease, Nationwide Data Show Poor Adherence by Patients to Medication and by Physicians to Guidelines A widespread approach that incorporates various stakeholders may be necessary to change adherence behavior.  |
Managed Care February 2008 |
Medication Payment Proposal Lets Consumers Pay Annually Researchers suggest an annual license fee that would entitle consumers to a year's worth of medication for each prescription they take to manage chronic diseases, with a very small or nonexistent copayment for each monthly supply.  |
| <Older 4651-4660 Newer> Return to current articles. |